Showing results (21-30 of 116) with videos related to

Sort By:
Pageof 12
Plos One|July 14, 2022
Threshold of increase in oxygen demand to predict mechanical ventilation use in novel coronavirus disease 2019: A retrospective cohort study incorporating restricted cubic spline regressionRyo Yamamoto, Ryo Takemura, Asako Yamamoto, et al.
Medicine|February 13, 2021
Integrated cognitive behavioral therapy for chronic pain: An open-labeled prospective single-arm trialKayoko Taguchi, Noriko Numata, Rieko Takanashi, et al.
BMC Gastroenterology|April 5, 2023
Early symptoms preceding post-infectious irritable bowel syndrome following COVID-19: a retrospective observational study incorporating daily gastrointestinal symptomsRyo Yamamoto, Asako Yamamoto, Tatsuhiro Masaoka, et al.
BMC Psychiatry|September 24, 2025
Videoconference-delivered cognitive behavioral therapy in patients with symptomatic panic disorder following primary pharmacotherapy: a randomized, assessor-blinded, controlled trialYoichi Seki, Ryo Takemura, Chihiro Sutoh, et al.
Internal Medicine (Tokyo, Japan)|January 5, 2025
Efficacy and Safety of Switching Between Anti-CGRP Monoclonal Antibodies: A Detailed Monthly and Long-term Follow-up Study and Literature ReviewKota Oshima, Keiko Ihara, Narumi Watanabe, et al.
Annals of Surgical Oncology|March 29, 2022
Exposure to a Postoperative Hypercoagulable State Predicts Poor Prognosis After Transthoracic Esophagectomy in Patients with Esophageal CancerJunichi Sano, Satoru Matsuda, Hirofumi Kawakubo, et al.
Neurology and Therapy|January 4, 2024
Impact of Migraine on Daily Life: Results of the Observational survey of the Epidemiology, Treatment, and Care of Migraine (OVERCOME [Japan]) StudyEtsuko Awaki, Takao Takeshima, Yasuhiko Matsumori, et al.
Journal of the Neurological Sciences|September 27, 2023
Switching between anti-calcitonin gene-related peptide monoclonal antibodies: A comparison of monthly and quarterly dosingKeiko Ihara, Seiya Ohtani, Narumi Watanabe, et al.
Cancer Immunology Research|April 23, 2015
PolyI:C-Induced, TLR3/RIP3-Dependent Necroptosis Backs Up Immune Effector-Mediated Tumor Elimination In VivoRyo Takemura, Hiromi Takaki, Seiji Okada, et al.
Scientific Reports|March 20, 2021
Randomized, crossover clinical efficacy trial in humans and mice on tear secretion promotion and lacrimal gland protection by molecular hydrogenMiyuki Kubota, Motoko Kawashima, Sachiko Inoue, et al.
Pageof 12